Thermo Fisher Scientific

Name: Thermo Fisher Scientific
Address: Fraunhoferstr. 11, Martinsried, 82152, DE
Telephone: 49 2304 932 5

Startseite
Deutschland
Martinsried
Thermo Fisher Scientific

Kontaktinformationen, Karte und Wegbeschreibungen, Kontaktformulare, Öffnungszeiten, Dienstleistungen, Bewertungen, Fotos, Videos und Ankündigungen von Thermo Fisher Scientific, Biotechnologieunternehmen, Fraunhoferstr. 11, Martinsried.

29/05/2026

Preeclampsia remains one of the leading causes of maternal and infant complications worldwide, underscoring the need for continued awareness, education and collaboration across healthcare.

During Preeclampsia Awareness Month, we’re recognizing the importance of maternal health solutions that help clinicians assess risk earlier, support informed care decisions and improve access to evidence-based testing.

The introduction in Congress of the Preeclampsia Risk Evaluation and Evidence-Based Management Through Personalized Testing Act, known as the PREEMPT Act, reflects growing recognition of the need to improve maternal health risk assessment and access to care.

Together with clinicians, researchers, policymakers and advocacy organizations, we can help advance maternal health and support care teams working to protect families.

28/05/2026

Thank you to the scientists who named our Invitrogen™ EVOS™ S1000 Spatial Imaging System the Best New Life Sciences Product of 2025 in the 2026 SelectScience Scientists’ Choice Awards®.

This recognition is especially meaningful because it comes directly from scientists in labs around the world — the people using new technologies to study complex biology, capture spatial context and see details that can lead to new insights.

To everyone who voted, thank you. Your work keeps us focused on what matters most: helping scientists see more clearly, understand biology in deeper context and ask what’s next.

We’re grateful to support the discoveries you bring to life every day.

27/05/2026

A ribbon cutting is one moment. The work inside this new laboratory will support years of scientific progress.

We recently celebrated the opening of our new bioanalytical and biomarker laboratory in Gothenburg, Sweden, located within GoCo Health Innovation City.

The facility expands and strengthens support for pharmaceutical and biotechnology customers across every phase of drug development, from preclinical studies through post-approval. With advanced capabilities in cell-based assays, immunochemistry, liquid chromatography-mass spectrometry, molecular genomics, flow cytometry and proteomics, the lab is designed to help customers navigate the growing complexity of modern therapies.

“Our new Gothenburg laboratory is purpose-built to address the evolving needs of modern drug development, particularly as therapies become more complex and data requirements increase,” said Leon Wyszkowski, president, analytical services, clinical research, Thermo Fisher Scientific.

Behind this celebration is a clear purpose: helping customers generate reliable data, accelerate innovation and bring new therapies to patients faster.

Thank you to our colleagues, customers and partners in Sweden and around the world who are helping make this work possible.

26/05/2026

We recently welcomed Secretary of the Pennsylvania Department of Community and Economic Development Rick Siger and his team to our Millersburg, PA, manufacturing site.

During the visit, our colleagues highlighted how the site supports customers worldwide with single-use technologies that help accelerate the production of vaccines, biologics and other therapies for patients around the world.

Our colleagues also had the opportunity to discuss how advanced manufacturing and life sciences innovation are contributing to economic growth and supporting stronger communities across Pennsylvania.

Thank you to Secretary Siger and his team for visiting and learning more about the important work happening in Millersburg.

21/05/2026

At Monash University, our advanced mass spectrometry is helping scientists detect previously unseen molecular signals linked to disease progression, cancer and future therapies.

For years, much of the valuable information contained in blood’s liquid component, plasma, remained out of reach. Scientists could see plasma’s most abundant molecules, but many lower-abundance proteins, often key to understanding biological change, were harder to detect.

Using our Thermo Scientific™ Orbitrap™ Astral™ Mass Spectrometer, researchers at Monash are now uncovering protein patterns in blood and individual cells that may help explain how diseases develop, progress and respond to treatment.

“This is a quantum leap in proteomics, giving us a much better idea of what’s going on at the molecular level,” said Ralf Schittenhelm, professor and director of the Monash University Proteomics and Metabolomics Platform.

By helping bring hidden biology into view, we’re supporting researchers working to better understand disease and open new paths for future diagnostics and therapies.

Read more about how Monash researchers are bringing hidden biology into view: https://corporate.thermofisher.com/us/en/index/newsroom/Our-stories/Thermo-Fisher-Orbitrap-Astral-Impact.html

20/05/2026

Speed, complexity and resilience.

These are the factors behind a structural shift in Asia’s life sciences ecosystem, says Thermo Fisher’s Tony Acciarito.

“Speed, because patients and markets expect faster development. Complexity, because advanced therapies need tightly connected, highly controlled manufacturing systems. Resilience, because supply disruptions are no longer theoretical.”

As biopharma companies across Asia work to develop therapies faster and build more flexible supply networks, the opportunity is clear: bring expertise closer to where innovation is happening and build partnerships that help teams make critical decisions earlier.

That kind of collaboration can help reduce risk, support more resilient development pathways and move promising therapies closer to patients.

Learn more in this Q&A with Tony about how Thermo Fisher is supporting Asia’s growing life sciences ecosystem through local expertise, collaboration and bioprocessing support: https://corporate.thermofisher.com/us/en/index/newsroom/thought-leadership/asia-bioprocessing-boom-drug-development-thermo-fisher-tony-acciarito.html

13/05/2026

At our new U.S. flagship Bioprocess Design Center in Plainville, Massachusetts, customers can work side by side with our experts to solve challenges to speed the development and manufacturing of biologic medicines, helping promising therapies reach patients sooner.

In the 4,000-square-foot laboratory and training space, our colleagues will work with customers to test ideas, identify and resolve issues and optimize processes earlier in development. Because scaling biologics can be complex, this collaborative approach is designed to help customers reduce risk, make faster and more data-driven decisions, and find a clearer path from scientific promise to production.

The center also expands capabilities within our 290,000-square-foot Plainville facility and connects the U.S. to our global network of Bioprocess Design Centers across Asia.

Watch highlights from the opening and learn more: https://corporate.thermofisher.com/us/en/index/newsroom/Our-stories/Bioprocess-Design-Center-Plainville-Mass.html

12/05/2026

Clinical trials are complex, but the goal is simple: help medicines reach the patients who need them faster and more efficiently.

Thermo Fisher Scientific has been named a leader among contract research organizations, companies that help plan and run clinical trials, in the 2026 ISG Provider Lens™ Life Sciences Digital Services report.

The recognition reflects how our teams use AI, data and digital tools to help customers plan and run clinical trials, connect with patients, monitor safety information and meet health authority requirements.

That work can help reduce complexity, improve patient recruitment and retention, support trials that include both in-person and remote participation and help teams spot potential safety concerns earlier.

“We are focused on building a more connected, patient-centric and AI-enabled future for clinical research that helps our customers accelerate the delivery of safe and effective therapies to patients worldwide,” said Krishna Cheriath, vice president, head of clinical research digital and AI, biopharma services, Thermo Fisher Scientific.

Together with our customers, we are working to make clinical research easier to navigate, more accessible to patients and better equipped to help new therapies move through research more efficiently.

Read more: https://newsroom.thermofisher.com/newsroom/press-releases/press-release-details/2026/Thermo-Fisher-Scientifics-Clinical-Research-Business-Named-a-Leader-Among-CROs-in-2026-ISG-Provider-Lens-Report-for-Use-of-AI-in-Clinical-Trials/default.aspx

08/05/2026

Thermo Fisher Scientific has received the 2026 MedTech Breakthrough Award for Best New Technology Solution in Oncology for the Oncomine™ Comprehensive Assay Plus on the Ion Torrent™ Genexus™ System. This technology is designed to help researchers better understand cancer samples as soon as the next day.

Cancer is not one disease. Even tumors that look similar can be driven by different genetic changes. Understanding those changes can help researchers learn what may be happening inside a tumor and support the future of more personalized care.

The challenge is time. Traditional testing can take days or weeks, and researchers may need to run multiple tests to get a fuller picture.

Our Oncomine™ Comprehensive Assay Plus on the Ion Torrent™ Genexus™ System helps change that. It looks at 517 cancer-related genes in one process, giving research teams a broad view of a tumor sample without waiting weeks for results.

By making this kind of testing faster and easier for more labs to use, we can help researchers reach meaningful insights sooner.

Thank you to our colleagues whose work is helping make faster, more comprehensive cancer insights possible when timing matters.

07/05/2026

The largest study to date on how genetics regulate blood protein levels is offering new insight into the underlying mechanisms of several diseases and potential future therapy options to treat them.

In a multi-institutional study published in Cell, an international research team of 118 investigators from 89 institutions analyzed protein and genetic data from more than 78,000 participants across 38 cohorts. The work identified thousands of genetic links to circulating blood proteins, helping reveal biological pathways that may accelerate discovery of new drug targets or drug repurposing.

Study teams used Olink™ technology, including Olink Target 96 panels and Olink Explore 1536, to measure circulating proteins across large population cohorts and connect those measurements with genetic data at scale.

This work reflects the power of global scientific collaboration and shows how population-scale proteomics can help researchers turn blood-based protein signals into deeper insight into health and disease.

06/05/2026

In Northern Ireland, blue-green algae blooms across Lough Neagh raised urgent questions about water safety for millions of people who rely on the lake for safe drinking water.

Swipe through to learn how the Northern Ireland Water team, with the support of our advanced analytical instruments, took action to keep communities safe.

Adresse

Fraunhoferstr. 11
Martinsried
82152

Telefon

49 2304 932 5

Webseite

https://www.thermofisher.com/

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von Thermo Fisher Scientific erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.